The United States imposed a blockade against Cuba in 1961, and currently there isn’t much collaboration — or even, much communication — about medical…
The majority of experimental Alzheimer’s drugs are being designed to halt the progression of the disease — a strategy which so far has yielded…
The approval of the controversial anti-amyloid drug Aduhelm last year marked a major milestone for Alzheimer’s research — it became the first new drug…
Could insulin treat Alzheimer’s the same way it treats diabetes? Evidence shows Alzheimer’s might be more similar to a metabolic disorder, like diabetes, than…
When people log in to join a Jewish Family & Children’s Service memory cafe online, they might hear from an Afro-Latin music expert about…
New data presented at CTAD about an existing agitation drug, brexpiprazole, in trials for patients with Alzheimer’s, bears potential good news when it comes…
About 90 percent of people with Alzheimer’s disease show behavioral symptoms like agitation, irritability, and anger during the course of the disease. If a caregiver…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. After Kunle Adewale’s stepmother had a stroke,…
Hello from the CTAD Alzheimer’s research conference in San Francisco, where I am attending this year’s meeting on the latest announcements on Alzheimer’s disease…
Much anticipated Phase 3 data for Alzheimer’s drug lecanemab was presented at CTAD in 2022, showing the drug is as safe as the placebo…
Alzheimer’s disease is a progressive disorder without a cure. While there are drugs which treat many of the symptoms — brain fog, cognitive impairment,…
Journalist and Alzheimer’s advocate Phil Gutis, who is living with early onset Alzheimer’s, shares some wisdom this Giving Tuesday. Another Thanksgiving has come and…
Update 27 January, 2023: In January 2023, lecanemab was granted accelerated approval by the FDA and made available to patients under the brand name…
Here are some of Being Patient’s favorite gift ideas for people with dementia during the holiday season, designed specifically for people living with dementia that…
More than 6.5 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to more than double. One in 3…